Improvement of the solubility of problem drugs. 18. Iomeglamic acid-PVA effervescent powder
Fahr, F.; Kala, H.; Fries, G.; Helbig, G.
Die Pharmazie 43(3): 217
1988
ISSN/ISBN: 0031-7144 PMID: 3380871 Document Number: 309241
Document emailed within 1 workday
Related Documents
Fahr, F.; Kala, H.; Hückel, T.; Fries, G. 1988: Improvement of the solubility of problem drugs. 17. Processing of iomeglamic acid/methylcellulose coprecipitates in tablets Die Pharmazie 43(3): 216Fahr, F.; Kala, H.; Diallo, B.; Metzner, J. 1985: The enhancement of solubility of problem drugs. 5. Solubility of griseofulvin-methylcellulose-PEG coprecipitates Die Pharmazie 40(5): 362-363
Pfeifer, S.; Schäffner, J.; Bornschein, I. 1972: Biotransformation of iomeglamic acid (Falignost) Die Pharmazie 27(9): 616-617
Lindberg, N.O. 1970: Preparation of effervescent tablets containing nicotinic acid and sodium bicarbonate Acta Pharmaceutica Suecica 7(1): 23-28
George, J.; Majeed, W.; Mackenzie, I.S.; Macdonald, T.M.; Wei, L. 2013: Association between cardiovascular events and sodium-containing effervescent, dispersible, and soluble drugs: nested case-control study Bmj 347: F6954
Mertz, D.P. 1978: The uric acid-lowering action of benzbromarone effervescent granules and allopurinol. Comparative studies Münchener Medizinische Wochenschrift 120(42): 1387-1390
Groning, R.; Braun, F.J. 1996: Three-dimensional solubility parameters and their use in characterising the permeation of drugs through the skin Die Pharmazie 51(5): 337-341
Jürgens, K.; Müller, B.W. 2005: A new formulation concept for drugs with poor water solubility for parenteral application Die Pharmazie 60(9): 665-670
Libinson, G.S. 1982: Standardization of antibiotics. Acid-base properties and solubility Antibiotiki 27(3): 207-221
Krowczynski, L. 1982: Technological methods for improving the solubility and increasing the dissolution rate of slightly soluble drugs Die Pharmazie 37(1): 79-83
Thangadurai, S.; Shukla, S.K.; Srivastava, A.K.; Anjaneyulu, Y. 2003: X-ray powder diffraction patterns for certain fluoroquinolone antibiotic drugs Acta Pharmaceutica 53(4): 295-303
Keipert, S.; Alde, D. 1986: Interaction between macromolecular adjuvants and drugs. 25. the effect of cellulose ether on the solubility characteristics of benzodiazepine derivatives Die Pharmazie 41(12): 845-849
Norpoth, K.; Nehrkorn, A.; Kirchner, M.; Holsen, H.; Teipel, H. 1973: Studies on the problem of solubility and stability of steroid ovulation inhibitors in water, waste water and activated sludge Zentralblatt für Bakteriologie Parasitenkunde Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe B: Hygiene Praventive Medizin 156(6): 500-511
Tóth, Z.; Zimmermann, P.; Gintner, Z.; Bánóczy, J. 1989: Changes of acid solubility and fluoride content of the enamel surface in children consuming fluoridated milk Acta Physiologica Hungarica 74(2): 135-140
Fábián, T.; Fejérdy, P. 1972: The effect of quantitative and qualitative protein deficiency on the acid solubility of incisors in experimental animals Fogorvosi Szemle 65(3): 65-67
Desai, H.G.; Gala, G.M.; Contractor, Q.Q.; Kalro, R.H. 1984: Effect of red chilli powder on gastric acid secretion Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 3(2): 85-86
Chalabala, M.; Starha, L.; Muzik, M. 1972: Peroral long-acting drugs. VII. Tablets prepared of a granulated powder coated with fatty acids Ceskoslovenska Farmacie 21(4): 153-155
Chen, L.-H.; Yue, G.-C.; Guan, Y.-M.; Yang, M.; Zhu, W.-F. 2014: Impact of directly compressed auxiliary materials on powder property of fermented cordyceps powder Zhongguo Zhong Yao Za Zhi 39(1): 65-70
Kubis, A. 1976: Studies on the liberation of solubilized drugs from ointment bases. 3. Influence of various solubility-mediators in the presence of Span 20 on the liberation of chloramphenicol from emulsion ointments Die Pharmazie 31(7): 475-477
Gołkiewicz, W.; Bartos, A. 1993: Determination of trace amounts of salicylic acid and acetylsalicylic acid in polopirin and other drugs containing acetylsalicylic acid Acta Poloniae Pharmaceutica 50(2-3): 143-147